A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression

Journal of Clinical Investigation

Volumn 113, Issue 8, 2004, Pages 1234-1242

  Cerutti, Janete M ^a   Delcelo, Rosana ^a   Amadei, Marcelo João ^a   Nakabashi, Claudia ^a   Maciel, Rui M B ^a   Peterson, Bercedis ^b   Shoemaker, Jennifer ^b   Riggins, Gregory J ^c,d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; GENE PRODUCT; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INTEGRAL MEMBRANE PROTEIN 1; KEXIN; PROTEIN NIBAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARG2 GENE; ARTICLE; ASPIRATION BIOPSY; C1 GENE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DDIT3 GENE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; F42 GENE; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ITM1 GENE; MALE; MEDICAL DECISION MAKING; NUCLEOTIDE SEQUENCE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; THYROID ADENOMA; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID TUMOR; VALIDATION PROCESS;

EID: 2142702917     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI19617     Document Type: Article

References (55)

1. Gharib, H. 1994. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin. Proc. 69:44-49.
2. Mazzaferri, E.L. 1993. Management of a solitary thyroid nodule. N. Engl. J. Med. 328:553-559.
3. Goellner, J.R., Gharib, H., Grant, C.S., and Johnson, D.A. 1987. Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol. 31:587-590.
4. Inohara, H., et al. 1999. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer. 85:2475-2484.
5. Bartolazzi, A., et al. 2001. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet. 357:1644-1650.
6. Xu, X.C., el-Naggar, A.K., and Lotan, R. 1995. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am. J. Pathol. 147:815-822.
7. Cvejic, D., et al. 1998. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res. 18:2637-2641.
8. Bernet, V.J., et al. 2002. Determination of galectin-3 messenger ribonucleic acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. J. Clin. Endocrinol. Metab. 87:4792-4796.
9. Kroll, T.G., et al. 2000, PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma [erratum 2000, 289:1474]. Science. 289:1357-1360.
10. Marques, A.R., et al. 2002. Expression of PAX8-PPARγ1 rearrangements in both follicular thyroid carcinomas and adenenomas J. Clin. Endocrinol. Metab. 87:3947-3952.
11. Nikiforova, M.N., Biddinger, P.W., Caudill, C.M., Kroll, T.G., and Nikiforov, Y.E. 2002. PAX8-PPARγ rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am. J. Surg. Pathol. 26:1016-1023.
12. Cheung, L., et al. 2003. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. J. Clin. Endocrinol. Metab. 88:354-357.
13. Fagin, J.A. 1995. Tumor suppressor genes in human thyroid neoplasms: p53 mutations are associated undifferentiated thyroid cancers. J. Endocrinol. Invest. 18:140-142.
14. Haugen, B.R., et al. 1997. Telomerase activity in benign and malignant thyroid tumors. Thyroid. 7:337-342.
15. Sack, M.J., Astengo-Osuna, C., Lin, B.T., Battifora, H., and LiVolsi, V.A. 1997. HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Mod. Pathol. 10:668-674.
16. Barden, C.B., et al. 2003. Classification of fillicular thyroid tumors by molecular signature: results of gene profiling. Clin. Cancer Res. 9:1792-1800.
17. Velculescu, V.E., Zhang, L., Vogelstein, B., and Kinzler, K.W. 1995. Serial analysis of gene expression. Science. 270:484-487.
18. Zhang, L., et al. 1997. Gene expression profiles in normal and cancer cells. Science. 276:1268-1272.
19. Velculescu, V.E., et al. 1999. Analysis of human transcriptomes. Nat. Genet. 23:387-388.
20. Pang, X.P., Hershman, J.M., Chung, M., and Pekary, A.E. 1989. Characterization of tumor necrosis factor-alpha receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology. 125:1783-1788.
21. Cerutti, J., et al. 1996. Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines. Clin. Cancer Res. 2:119-126.
22. Visconti, R., et al. 1997. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaβ p65 protein expression. Oncogene. 15:1987-1994.
23. Simon, R., Radmacher, M.D., Dobbin, K., and McShane, L.M. 2003. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J. Natl. Cancer Inst. 95:14-18.
24. Radmacher, M.D., McShane, L.M., and Simon, R. 2002. A paradigm for class prediction using gene expression profiles. J. Comput. Biol. 9:505-511.
25. Kramer, M.S., and Feinstein, A.R. 1981. Clinical biostatistics LIV: the biostatistics of concordance. Clin. Pharmacol. Ther. 29:111-123.
26. Pauws, E. van Kampen, A.H., van de Graaf, S.A., de Vijlder, J.J., and Ris-Stalpers, C. 2001. Heterogeneity in polyadenylation cleavage sites in mammalian mRNA sequences: implications for SAGE analysis. Nucleic Acids Res. 29:1690-1694.
27. Takano, T., et al. 2000. Gene expression profiles in thyroid carcinomas. Br. J. Cancer. 83:1495-1502.
28. Jin, K., et al. 2002. cDNA microarray analysis of changes in gene expression induced by neuronal hypoxia in vitro. Neurochem. Res. 27:1105-1112.
29. Talukdet, A.H., Wang, R.A., and Kumar, R. 2002. Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells. Oncogene. 21:4289-4300.
30. Nikiforova, M.N., et al. 2003. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J. Clin. Endocrinol. Metab. 88:2318-2326.
31. Brenner, B., et al. 1997. Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J. Biol. Chem. 272:22173-22181.
32. Satoh, T., et al. 2002. Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells. Oncogene. 21:2171-2180.
33. Hong, G., et al. 1996 Molecular cloning of a highly conserved mouse and human integral membrane protein (Itm1) and genetic mapping to mouse chromosome 9. Genomics. 31:295-300.
34. Van Hul, W., et al. 1996. Assignment of the human integral transmembrane protein 1 gene (ITM1) to human chromosome band 11q23.3 by in situ hybridization and YAC mapping. Cytogenet. Cell Genet. 74:218-219.
35. Meerabux, J.M., et al. 1994. Molecular cloning of a novel 11q23 breakpoint associated with non-Hodgkin's lymphoma. Oncogene. 9:893-898.
36. Matsuo, K., Tang, S.H., and Fagin, J.A. 1991. Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms. Mol. Endocrinol. 5:1873-1879.
37. Ward, L.S., Brenta, G., Medvedovic, M., and Fagin, J.A. 1998. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. J. Clin. Endocrinol. Metab. 83:525-530.
38. Gotoh, T., Araki, M., and Mori, M. 1997. Chromosomal localization of the human arginase II gene and tissue distribution of its mRNA. Biochem. Biophys. Res. Commun. 233:487-491.
39. Morris, S.M., Jr., Bhamidipati, D., and Kepka-Lenhart, D. 1997. Human type II arginase: sequence analysis and tissue-specific expression. Gene. 193:157-161.
40. Russell, D.H., and McVicker, T.A. 1972. Polyamine biogenesis in the rat mammary gland during pregnancy and lactation. Biochem. J. 130:71-76.
41. Tian, W., Boss, G.R., and Cohen, D.M. 2000. Ras signaling in the inner medullary cell response to urea and NaCl. Am. J. Physiol. Cell Physiol. 278:C372-C380.
42. Majima, S., Kajino, K., Fukuda, T., Otsuka, F., and Hino, O. 2000. A novel gene "Niban" upregulated in renal carcinogenesis: cloning by the cDNA-amplified fragment length polymprphism approach. Jpn. J. Cancer Res. 91:869-874.
43. Sood, R., et al. 2001. Cloning and characterization of 13 novel transcripts and the human RGS8 gene from the 1q25 region encompassing the hereditary prostate cancer (HPCl) locus. Genomics. 73:211-222.
44. Matsuda, S., et al. 2001. Cloning and sequencing of a novel human gene that encodes a putative target protein of Nesh-SH3 J. Hum. Genet. 46:483-486.
45. Ichigotani, Y., Yokozaki, S., Fukuda, Y., Hamaguchi, M., and Matsuda, S. 2002. Forced expression of NESH suppresses motility and metastatic dissemination of malignant cells. Cancer Res. 62:2215-2219.
46. Zedenius, J., et al. 1995 Allelotyping of follicular thyroid tumors. Hum. Genet. 96:27-32.
47. Roque, L., Rodrigues, R., Pinto, A., Moura-Nunes, V., and Soares, J. 2003. Chromosome imbalances in thyroid follicular neoplasms: a comparison between follicular adenomas and carcinomas. Genes Chromosomes Cancer. 36:292-302.
48. Grebe, S.K., et al. 1997. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. J. Clin. Endocrinol. Metab. 82:3684-3691.
49. Fonseca, E., Soares, P., Rossi, S., and Sobrinho-Simoes, M. 1997. Prognostic factors in thyroid carcinomas. Verh. Dtsch. Ges. Pathol. 81:82-96.
50. St Croix, B., et al. 2000. Genes expressed in human tumor endothelium. Science. 289:1197-1202.
51. Lal, A., et al. 1999. A public database for gene expression in human cancers. Cancer Res. 59:5403-5407.
52. Boon, K., et al. 2002. An anatomy of normal and malignant gene expression. Proc. Natl. Acad. Sci. U. S. A. 99:11287-11292.
53. Buckhaults, P., et al. 2001. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res. 61:6996-7001.
54. Tukey, J.W. 1993. Tightening the clinical trial. Control. Clin. Trials. 14:266-285
55. The Cancer Genome Anatomy Project. All about the CGAP GO browser. http://cgap.nci.nih.gov/Genes/AllAboutGO.